Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.
Do you want to accelerate your structure verification without compromise? Join us on Wednesday December 11th to learn how. Register Now!
Technology Networks spoke with ACD/Labs’ Andrew Anderson about how the field of biochemical research is being changed by automation and how our new product, Katalyst D2D, hopes to speed up pharmaceutical development.